Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated.
Motion to recall and re-refer, motion prevailed
Email me when HF 4577 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HF 4577. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill sets up a regulated psilocybin therapeutic use program for adults 21 and older who have a qualifying medical condition. It registers patients, suppliers, facilitators and protects participating health‑care providers, while establishing fees, data rules, and civil penalties for misuse. The measure also creates an advisory committee and earmarks state funds to run the program.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HF 4577
3 free questions a day, no accountHistory
- Motion to recall and re-refer, motion prevailed Veterans and Military Affairs Division
- Introduction and first reading, referred to Health Finance and Policy
Sponsors
- Rymer · sponsor
- Bliss
- Gordon
- Smith
- West
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HF 4577 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HF 4577 freeOr ask your AI assistant about HF 4577 directly:
Add to Claude, ChatGPT or Cursor